nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentobarbital—GABRA3—Graves' disease	0.625	1	CbGaD
Pentobarbital—CYP2A6—Methimazole—Graves' disease	0.184	0.62	CbGbCtD
Pentobarbital—CYP2C19—Methimazole—Graves' disease	0.0761	0.256	CbGbCtD
Pentobarbital—CYP3A4—Methimazole—Graves' disease	0.0368	0.124	CbGbCtD
Pentobarbital—GABRA6—GABA A receptor activation—GABRA3—Graves' disease	0.00309	0.0484	CbGpPWpGaD
Pentobarbital—GABRA4—GABA A receptor activation—GABRA3—Graves' disease	0.00305	0.0478	CbGpPWpGaD
Pentobarbital—GABRB2—GABA A receptor activation—GABRA3—Graves' disease	0.00279	0.0437	CbGpPWpGaD
Pentobarbital—GABRA5—GABA A receptor activation—GABRA3—Graves' disease	0.00271	0.0424	CbGpPWpGaD
Pentobarbital—GABRA2—GABA A receptor activation—GABRA3—Graves' disease	0.00262	0.041	CbGpPWpGaD
Pentobarbital—GABRB3—GABA A receptor activation—GABRA3—Graves' disease	0.0026	0.0407	CbGpPWpGaD
Pentobarbital—GABRG2—GABA A receptor activation—GABRA3—Graves' disease	0.00255	0.0399	CbGpPWpGaD
Pentobarbital—GABRA1—GABA A receptor activation—GABRA3—Graves' disease	0.00223	0.0349	CbGpPWpGaD
Pentobarbital—GABRA6—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00189	0.0296	CbGpPWpGaD
Pentobarbital—GABRA4—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00187	0.0292	CbGpPWpGaD
Pentobarbital—GABRB2—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00171	0.0267	CbGpPWpGaD
Pentobarbital—GABRA5—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00166	0.026	CbGpPWpGaD
Pentobarbital—GABRA2—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.0016	0.0251	CbGpPWpGaD
Pentobarbital—GABRB3—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00159	0.0249	CbGpPWpGaD
Pentobarbital—Liver injury—Propylthiouracil—Graves' disease	0.00158	0.209	CcSEcCtD
Pentobarbital—GABRG2—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00156	0.0245	CbGpPWpGaD
Pentobarbital—GABRA1—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00137	0.0214	CbGpPWpGaD
Pentobarbital—Dermatitis exfoliative—Propylthiouracil—Graves' disease	0.00102	0.135	CcSEcCtD
Pentobarbital—GABRA6—GABA receptor activation—GABRA3—Graves' disease	0.001	0.0157	CbGpPWpGaD
Pentobarbital—GABRA4—GABA receptor activation—GABRA3—Graves' disease	0.000992	0.0155	CbGpPWpGaD
Pentobarbital—Heptabarbital—GABRA3—Graves' disease	0.000913	0.138	CrCbGaD
Pentobarbital—GABRB2—GABA receptor activation—GABRA3—Graves' disease	0.000907	0.0142	CbGpPWpGaD
Pentobarbital—GABRA5—GABA receptor activation—GABRA3—Graves' disease	0.000881	0.0138	CbGpPWpGaD
Pentobarbital—GABRA2—GABA receptor activation—GABRA3—Graves' disease	0.00085	0.0133	CbGpPWpGaD
Pentobarbital—GABRB3—GABA receptor activation—GABRA3—Graves' disease	0.000845	0.0132	CbGpPWpGaD
Pentobarbital—GABRG2—GABA receptor activation—GABRA3—Graves' disease	0.00083	0.013	CbGpPWpGaD
Pentobarbital—Butethal—GABRA3—Graves' disease	0.000791	0.12	CrCbGaD
Pentobarbital—Butalbital—GABRA3—Graves' disease	0.000772	0.117	CrCbGaD
Pentobarbital—Aprobarbital—GABRA3—Graves' disease	0.000762	0.115	CrCbGaD
Pentobarbital—Thiopental—GABRA3—Graves' disease	0.000745	0.113	CrCbGaD
Pentobarbital—Amobarbital—GABRA3—Graves' disease	0.000736	0.111	CrCbGaD
Pentobarbital—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000726	0.0114	CbGpPWpGaD
Pentobarbital—GABRA1—GABA receptor activation—GABRA3—Graves' disease	0.000725	0.0113	CbGpPWpGaD
Pentobarbital—Thiamylal—GABRA3—Graves' disease	0.000663	0.1	CrCbGaD
Pentobarbital—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000661	0.0103	CbGpPWpGaD
Pentobarbital—Secobarbital—GABRA3—Graves' disease	0.000656	0.0993	CrCbGaD
Pentobarbital—GABRA6—Orphan transporters—GABRA3—Graves' disease	0.000586	0.00916	CbGpPWpGaD
Pentobarbital—GABRA4—Orphan transporters—GABRA3—Graves' disease	0.000578	0.00905	CbGpPWpGaD
Pentobarbital—Talbutal—GABRA3—Graves' disease	0.000568	0.086	CrCbGaD
Pentobarbital—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000555	0.00869	CbGpPWpGaD
Pentobarbital—GRIK2—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000546	0.00854	CbGpPWpGaD
Pentobarbital—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000539	0.00842	CbGpPWpGaD
Pentobarbital—GABRB2—Orphan transporters—GABRA3—Graves' disease	0.000529	0.00828	CbGpPWpGaD
Pentobarbital—GABRA5—Orphan transporters—GABRA3—Graves' disease	0.000514	0.00804	CbGpPWpGaD
Pentobarbital—CHRNA7—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000497	0.00777	CbGpPWpGaD
Pentobarbital—GABRA2—Orphan transporters—GABRA3—Graves' disease	0.000496	0.00776	CbGpPWpGaD
Pentobarbital—Somnolence—Methimazole—Graves' disease	0.000496	0.0656	CcSEcCtD
Pentobarbital—GABRB3—Orphan transporters—GABRA3—Graves' disease	0.000493	0.00771	CbGpPWpGaD
Pentobarbital—GABRG2—Orphan transporters—GABRA3—Graves' disease	0.000484	0.00757	CbGpPWpGaD
Pentobarbital—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000462	0.00722	CbGpPWpGaD
Pentobarbital—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000456	0.00713	CbGpPWpGaD
Pentobarbital—Body temperature increased—Methimazole—Graves' disease	0.000441	0.0584	CcSEcCtD
Pentobarbital—GABRA1—Orphan transporters—GABRA3—Graves' disease	0.000423	0.00662	CbGpPWpGaD
Pentobarbital—Somnolence—Propylthiouracil—Graves' disease	0.000421	0.0558	CcSEcCtD
Pentobarbital—GRIK2—Neuronal System—GABRA3—Graves' disease	0.000418	0.00654	CbGpPWpGaD
Pentobarbital—GRIA2—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000417	0.00653	CbGpPWpGaD
Pentobarbital—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000417	0.00652	CbGpPWpGaD
Pentobarbital—GABRA6—Ion channel transport—GABRA3—Graves' disease	0.000411	0.00643	CbGpPWpGaD
Pentobarbital—GABRA4—Ion channel transport—GABRA3—Graves' disease	0.000406	0.00635	CbGpPWpGaD
Pentobarbital—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000405	0.00634	CbGpPWpGaD
Pentobarbital—CHRNA4—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000405	0.00633	CbGpPWpGaD
Pentobarbital—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000391	0.00612	CbGpPWpGaD
Pentobarbital—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000388	0.00608	CbGpPWpGaD
Pentobarbital—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000381	0.00597	CbGpPWpGaD
Pentobarbital—CHRNA7—Neuronal System—GABRA3—Graves' disease	0.000381	0.00595	CbGpPWpGaD
Pentobarbital—Body temperature increased—Propylthiouracil—Graves' disease	0.000375	0.0496	CcSEcCtD
Pentobarbital—GABRB2—Ion channel transport—GABRA3—Graves' disease	0.000371	0.00581	CbGpPWpGaD
Pentobarbital—GABRA5—Ion channel transport—GABRA3—Graves' disease	0.000361	0.00564	CbGpPWpGaD
Pentobarbital—Vomiting—Methimazole—Graves' disease	0.000354	0.047	CcSEcCtD
Pentobarbital—Rash—Methimazole—Graves' disease	0.000352	0.0466	CcSEcCtD
Pentobarbital—Dermatitis—Methimazole—Graves' disease	0.000351	0.0465	CcSEcCtD
Pentobarbital—Headache—Methimazole—Graves' disease	0.000349	0.0463	CcSEcCtD
Pentobarbital—GABRA2—Ion channel transport—GABRA3—Graves' disease	0.000348	0.00544	CbGpPWpGaD
Pentobarbital—GABRA6—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000347	0.00543	CbGpPWpGaD
Pentobarbital—GABRB3—Ion channel transport—GABRA3—Graves' disease	0.000346	0.00541	CbGpPWpGaD
Pentobarbital—GABRA4—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000343	0.00536	CbGpPWpGaD
Pentobarbital—GABRG2—Ion channel transport—GABRA3—Graves' disease	0.000339	0.00531	CbGpPWpGaD
Pentobarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000333	0.00522	CbGpPWpGaD
Pentobarbital—Nausea—Methimazole—Graves' disease	0.000331	0.0439	CcSEcCtD
Pentobarbital—GRIA2—Neuronal System—GABRA3—Graves' disease	0.00032	0.005	CbGpPWpGaD
Pentobarbital—GABRB2—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000314	0.0049	CbGpPWpGaD
Pentobarbital—CHRNA4—Neuronal System—GABRA3—Graves' disease	0.00031	0.00485	CbGpPWpGaD
Pentobarbital—GABRA5—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000305	0.00476	CbGpPWpGaD
Pentobarbital—Vomiting—Propylthiouracil—Graves' disease	0.000301	0.0399	CcSEcCtD
Pentobarbital—Rash—Propylthiouracil—Graves' disease	0.000299	0.0396	CcSEcCtD
Pentobarbital—Dermatitis—Propylthiouracil—Graves' disease	0.000299	0.0396	CcSEcCtD
Pentobarbital—Headache—Propylthiouracil—Graves' disease	0.000297	0.0393	CcSEcCtD
Pentobarbital—GABRA1—Ion channel transport—GABRA3—Graves' disease	0.000297	0.00464	CbGpPWpGaD
Pentobarbital—GABRA2—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000294	0.0046	CbGpPWpGaD
Pentobarbital—GABRB3—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000292	0.00457	CbGpPWpGaD
Pentobarbital—GABRG2—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000287	0.00449	CbGpPWpGaD
Pentobarbital—Nausea—Propylthiouracil—Graves' disease	0.000282	0.0373	CcSEcCtD
Pentobarbital—GABRA6—Neuronal System—GABRA3—Graves' disease	0.000266	0.00416	CbGpPWpGaD
Pentobarbital—GABRA4—Neuronal System—GABRA3—Graves' disease	0.000263	0.00411	CbGpPWpGaD
Pentobarbital—GABRA1—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000251	0.00392	CbGpPWpGaD
Pentobarbital—GABRB2—Neuronal System—GABRA3—Graves' disease	0.00024	0.00376	CbGpPWpGaD
Pentobarbital—GABRA5—Neuronal System—GABRA3—Graves' disease	0.000233	0.00365	CbGpPWpGaD
Pentobarbital—GABRA2—Neuronal System—GABRA3—Graves' disease	0.000225	0.00352	CbGpPWpGaD
Pentobarbital—GABRB3—Neuronal System—GABRA3—Graves' disease	0.000224	0.0035	CbGpPWpGaD
Pentobarbital—GABRG2—Neuronal System—GABRA3—Graves' disease	0.00022	0.00344	CbGpPWpGaD
Pentobarbital—GABRA1—Neuronal System—GABRA3—Graves' disease	0.000192	0.003	CbGpPWpGaD
Pentobarbital—GABRA6—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000143	0.00224	CbGpPWpGaD
Pentobarbital—GABRA4—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000141	0.00221	CbGpPWpGaD
Pentobarbital—GABRB2—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000129	0.00202	CbGpPWpGaD
Pentobarbital—GABRA5—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000125	0.00196	CbGpPWpGaD
Pentobarbital—GABRA2—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000121	0.00189	CbGpPWpGaD
Pentobarbital—GABRB3—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.00012	0.00188	CbGpPWpGaD
Pentobarbital—CHRNA7—SIDS Susceptibility Pathways—IL1B—Graves' disease	0.000119	0.00186	CbGpPWpGaD
Pentobarbital—GABRG2—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000118	0.00185	CbGpPWpGaD
Pentobarbital—GABRA1—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000103	0.00162	CbGpPWpGaD
Pentobarbital—CHRNA4—SIDS Susceptibility Pathways—IL1B—Graves' disease	9.7e-05	0.00152	CbGpPWpGaD
Pentobarbital—CHRNA7—SIDS Susceptibility Pathways—TNF—Graves' disease	8.63e-05	0.00135	CbGpPWpGaD
Pentobarbital—CHRNA4—SIDS Susceptibility Pathways—TNF—Graves' disease	7.04e-05	0.0011	CbGpPWpGaD
Pentobarbital—GABRA1—SIDS Susceptibility Pathways—IL1B—Graves' disease	6e-05	0.000939	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—GC—Graves' disease	6e-05	0.000939	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—GC—Graves' disease	4.38e-05	0.000686	CbGpPWpGaD
Pentobarbital—GABRA1—SIDS Susceptibility Pathways—TNF—Graves' disease	4.36e-05	0.000681	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—B3GNT2—Graves' disease	3.32e-05	0.00052	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—GC—Graves' disease	2.67e-05	0.000418	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—B3GNT2—Graves' disease	2.03e-05	0.000317	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—GC—Graves' disease	1.61e-05	0.000251	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—B3GNT2—Graves' disease	1.22e-05	0.000191	CbGpPWpGaD
